A college detour away from medical school and into scientific research worked to the advantage of Lori-Ann Christie. Her career has evolved from academic researcher to pharmaceutical industry scientist and director to venture capital fund principal, with each role building on the one before.

Christie recently joined Visionary Venture Fund, a capital firm that focuses on ophthalmology devices and pharmaceuticals. She assumed her investment-based role after seven years at Allergan, now part of AbbVie. Through all Allergan’s internal developments, Christie stepped up, asked questions, and learned from her mistakes. When Allergan integrated into AbbVie, she moved into a director role and got to experience all that comes after her work in the lab.

With host Ehsan Sadri, MD, Christie talks about her career trajectory, what she’s learned along the way, and what’s on the horizon.

Listen to the podcast today to discover:

• The difference between academic and pharmaceutical industry research and why scientific rigor matters.
• Her experience as part of Allergan’s diligence team.
• Why the eye is a great vehicle for experiments.
• Her take on emerging scientific and technologic advances that have the most potential.